Evaluating interventions to treat and prevent HIV infection and its consequences in infants, children, adolescents, and pregnant/postpartum women through the conduct of high quality clinical trials.
Last month, Dr. Farzan published a study in Nature that describes his team’s creation of a new molecule that prevents monkeys from being infected with simian/human immunodeficiency virus.
Exploring new methods to eradicate HIV that lingers in brain cells despite conventional antiviral treatment is the focus of a new study by investigators at Children’s Hospital and Temple University.
A Children’s Hospital of Philadelphia pediatrician’s research projects span across continents to Botswana, a sub-Saharan African country with a busy clinic for 2,000 HIV-infected children and adolescents who stole her heart.
Several researchers from The Children's Hospital of Philadelphia and the University of Pennsylvania were recently named Fellows of the American Association for the Advancement of Science (AAAS). Children's Hospital AIDS researcher and Pathologist-in-chief Robert W. Doms, MD, PhD, who also serves as chair of the Perelman School of Medicine's Department of Microbiology, was named an AAAS Fellow along with four
A group of prominent vaccine researchers, including The Children's Hospital of Philadelphia Research Institute's chief scientific officer, Philip R. Johnson, MD, and the University of Pennsylvania's Stanley Plotkin, MD, recently called for a "human vaccines project" to accelerate the development of vaccines to prevent "major global killers such as AIDS, tuberculosis, malaria, and other infectious diseases."
